home.aspx
 
EVENTS

Medicinal and Pharmaceutical Chemistry
MEDICINAL AND PHARMACEUTICAL CHEMISTRY
December 16-17, 2019
Medicinal Chemistry is the science of design and chemical synthesis focusing mainly on small organic molecules and their development of pharmaceutical agents, or bio-active molecules (drugs). Pharmaceutical Chemistry is the same plus the science of pharmaceutical and biomedical analysis to the synth...

International Conference on Metabolic Diseases and Liver Cancer
INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER
December 16-17, 2019
“INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ is organized in order to bring light and anticipate to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is effective on all sides as it giv...

Aurobindo Pharma

Among the largest 'Vertically Integrated'​ pharmaceutical companies in India, Aurobindo has robust product portfolio spread over major product areas encompassing CVS, CNS, Anti-Retroviral, Antibiotics, Gastroenterologicals, Anti-Diabetics and Anti-Allergic with approved manufacturing facilities by USFDA, UKMHRA, WHO, MCC-SA, ANVISA-Brazil for both APIs & Formulations and has Global presence with own infrastructure, strategic alliances, subsidiaries & joint ventures.

RELATED NEWS


Novartis multiple sclerosis med Gilenya is facing U.S. generic challengers on all sides to its blockbuster sales, and the company hoped a court order could stave them off. The Swiss drugmaker got what it asked for—and it might just keep the med at the top of Novartis’ bestseller list, at least for now. A suite of Gilenya competitors, including Mylan, Dr. Reddy’s Laboratories and Aurobindo Pharma, have been barred from immediately launching generic versions of the drug after a U...

READ MORE

In a quarter which saw its peers struggle, Aurobindo Pharma put out a strong March quarter performance. The company saw a 30.7 per cent growth in revenues, led by a strong 42.7 per cent growth in US sales.The geography is its single largest, accounting for 47 per cent of overall revenues. This was largely driven by the higher margin injectables business growth, with a ramp-up in antibacterial Ertapenem injection and new launches. The company launched 15 products, including four injectables in th...

READ MORE

Shares of Lupin and Aurobindo Pharma hit their respective fresh 52-week lows, extending their losses on BSE, after US drug regulator issued Form 483 with observations....

READ MORE

Drug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Ibandronate Sodium tablets....

READ MORE

Deutsche Bank is hopeful of better health of pharma stocks going forward due to easing regulatory concerns as well as actions by the US Food and Drug Administration (FDA). The brokerage remains constructive on stocks with superior earnings growth trajectory and strong execution track record. “We forecast the sector to post an 18% CAGR in FY16- 18 (20% CAGR over FY13-16), led by Sun Pharmaceuticals (32%), Aurobindo Pharma (21%) and Glenmark (45%),” the report said. Its top bets are Aurobindo ...

READ MORE

Indian company Aurobindo Pharma has acquired four cell culture-derived biosimilar products from Swiss-based TL Biopharmaceutical. Under the agreement, TL will supply all the developmental data for four molecules and the products will be globally developed, commercialised and marketed by Aurobindo and its affiliates....

READ MORE

Aurobindo Pharma Limited has received US Food &Drug Administration (USFDA) approval to make and market heartburn relief medicine Famotidine tablets of strengths 10 mg and 20 mg and Oxymorphone Hydrochloride Tablets of strengths 5 mg and 10 mg . The estimated market size for Famotidine for the 12 month period ending February 2016 was US$ 31 million whereas for Oxymorphone Hydrochloride Tablets, it is US$ 55.5 million for the same period as per data by IMS....

READ MORE

When 2016 began, the pharma industry in the State hoped to get an impetus in exports following promises to set up campus of Pharmaceuticals Export Promotion Council of India (Pharmexcil), National Institute of Pharmaceutical Education and Research (NIPER) and develop second pharma city. Other major units like Hetero at Nakkapalli, Divi’s Lab at Bhimili, Aurobindo Pharma at Pydibhimavaram, Reddy’s Labs at Ranasthalam and Duvvada have an estimated turnover of Rs. 20,000 crore making the total volu...
THEHINDU.COM
READ MORE

The generic drugmaker Aurobindo Pharma U.S.A. Inc. will not longer be pursuing $200,000 in incentives through the city of Durham. The city was alerted to the agreement termination in a letter from the company on September 6. The city council was told today in an email from city manager Tom Bonfield…...
INDY WEEK
READ MORE

US authorities have charged six companies of price fixing in the US, India, and Australia. Drugmakers Mylan, Heritage Pharmaceuticals, Teva Pharmaceutical USA and Citron Pharma are named in the lawsuit alongside India’s Aurobindo Pharma and Australia’s Mayne Pharmaceuticals....
ZME SCIENCE
READ MORE

EVENTS

Medicinal and Pharmaceutical Chemistry
MEDICINAL AND PHARMACEUTICAL CHEMISTRY
December 16-17, 2019
Medicinal Chemistry is the science of design and chemical synthesis focusing mainly on small organic molecules and their development of pharmaceutical agents, or bio-active molecules (drugs). Pharmaceutical Chemistry is the same plus the science of pharmaceutical and biomedical analysis to the synth...

Drug Formulation & Analytical Techniques
DRUG FORMULATION & ANALYTICAL TECHNIQUES
December 16-17, 2019
Pharmaceutical formulation in pharmaceutics is the process in which various chemical substances including the vigorous drug are joined to produce a final medicinal product. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally...